Antimicrobial resistance trends and outbreak frequency in United States hospitals

被引:200
作者
Diekema, DJ
BootsMiller, BJ
Vaughn, TE
Woolson, RF
Yankey, JW
Ernst, EJ
Flach, SD
Ward, MM
Franciscus, CLJ
Pfaller, MA
Doebbeling, BN
机构
[1] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA
[3] Univ Iowa, Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA
[4] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA
[5] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[6] Univ Iowa, Publ Policy Ctr, Iowa City, IA 52242 USA
关键词
D O I
10.1086/380457
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We assessed resistance rates and trends for important antimicrobial- resistant pathogens ( oxacillin- resistant Staphylococcus aureus [ ORSA], vancomycin- resistant Enterococcus species [ VRE], ceftazidime- resistant Klebsiella species [ K- ESBL], and ciprofloxacin- resistant Escherichia coli [ QREC]), the frequency of outbreaks of infection with these resistant pathogens, and the measures taken to control resistance in a stratified national sample of 670 hospitals. Four hundred ninety- four ( 74%) of 670 surveys were returned. Resistance rates were highest for ORSA ( 36%), followed by VRE ( 10%), QREC ( 6%), and K- ESBL ( 5%). Two- thirds of hospitals reported increasing ORSA rates, whereas only 4% reported decreasing rates, and 24% reported ORSA outbreaks within the previous year. Most hospitals ( 87%) reported having implemented measures to rapidly detect resistance, but only similar to 50% reported having provided appropriate resources for antimicrobial resistance prevention ( 53%) or having implemented antimicrobial use guidelines ( 60%). The most common resistant pathogen in US hospitals is ORSA, which accounts for many recognized outbreaks and is increasing in frequency in most facilities. Current practices to prevent and control antimicrobial resistance are inadequate.
引用
收藏
页码:78 / 85
页数:8
相关论文
共 35 条
[1]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P902
[2]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P565
[3]  
[Anonymous], ANTIMICROB AGENTS S
[4]   Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia [J].
Bach, PB ;
Malak, SF ;
Jurcic, J ;
Gelfand, SE ;
Eagan, J ;
Little, C ;
Sepkowitz, KA .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (08) :471-474
[5]  
BERENS MJ, 2002, CHICAGO TRIBUNE 0721, pA1
[6]   HOW TO USE RIDIT ANALYSIS [J].
BROSS, IDJ .
BIOMETRICS, 1958, 14 (01) :18-38
[7]  
*CDCP, 2002, CAMP PREV ANT RES HE
[8]  
*CDCP, 1992, MMWR-MORBID MORTAL W, V41, P783
[9]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1
[10]   Tracking drug-resistant Streptococcus pneumoniae in Oregon: An alternative surveillance method [J].
Chin, AE ;
Hedberg, K ;
Cieslak, PR ;
Cassidy, M ;
Stefonek, KR ;
Fleming, DW .
EMERGING INFECTIOUS DISEASES, 1999, 5 (05) :688-693